Nutranomics, Inc. (NNRX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 3, 2026
Nutranomics Revenue
In the fiscal year ending July 31, 2020, Nutranomics had annual revenue of $871.00, down -98.54%.
Revenue
871.00
Revenue Growth
-98.54%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
16.75K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2020 | 871.00 | -58.67K | -98.54% |
| Jul 31, 2019 | 59.54K | -1.73M | -96.67% |
| Jul 31, 2015 | 1.79M | -613.44K | -25.53% |
| Jul 31, 2014 | 2.40M | -455.43K | -15.93% |
| Jul 31, 2013 | 2.86M | -66.95K | -2.29% |
| Jul 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan General Group (China) | 80.38M |
| MPX International | 5.36M |
| EVIO, Inc. | 2.36M |
| Marijuana Company of America | 1.50M |
| Veritas Farms | 883.65K |
| Aeolus Pharmaceuticals | 771.00K |
| CaliPharms | 112.47K |
| AREV Life Sciences Global | 5.33K |